Overview

Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects

Status:
ENROLLING_BY_INVITATION

Trial end date:
2026-11-30

Target enrollment:

Participant gender:

Summary

This is a single-center, open-label, two-period, fixed-sequence clinical study to evaluate the effect of Itraconazole on the pharmacokinetics of HSK31858 in healthy subjects

Phase:

PHASE1

Details

Lead Sponsor:

Haisco Pharmaceutical Group Co., Ltd.

Treatments:

Itraconazole